Up to 90 per cent of cases of invasive pneumococcal diseases (IPD) - which includes serious infections get a kick out of meningitis - occur in in another situation in good young children, according to a weigh published in the April issue of IJCP, the International Documentation of Clinical Practice.
Yet a number of European countries still only vaccinate selected at-risk groups against IPD, despite growing evidence that universal vaccination of infants and young children reduces their risk and also provides added indirect “herd” protection for other unvaccinated members of the community.
Children in high risk groups include those with underlying medical conditions, such as sickle cell disease, HIV or diabetes.
The general European situation contrasts with the United States, which adopted universal vaccination with the 7-valent pneumococcal conjugate vaccine in August 2000, following the advice of the US Centers for Disease Control and Prevention (CDC) and the American Academy of Pediatrics.
The CDC recommended vaccinations for infants and children under two years-old, with catch-up vaccinations targeted at children aged two to five years with particular health problems. US authorities also highlighted the need for certain minority and ethnic groups to be added to the list, together with children attending day care.
A European assessment carried out by the authors in August 2005 showed that most countries - Belgium, Germany, Denmark, Finland, the UK, Ireland, Iceland, Norway, Portugal and Sweden - did not offer universal national or regional IPD immunisations, while Austria and France provided the most comprehensive guidelines for vaccinating at-risk groups.
Since then the UK Government has announced that the 7-valent pneumococcal conjugate vaccine will be added to childhood immunisation programmes from this year, pointing out the “immense impact” it has had in the US.
The Netherlands has also announced that the vaccine will be include in the national childhood immunisation programme from April 2006.
“Restricting pneumococcal immunisation to children who have a serious health problem that could make them more susceptible means that only a small percentage of the overall cases of childhood IPD may be prevented. Herd protection cannot be achieved without broad vaccine coverage” says lead author Dr Mark Fletcher, Director of International Scientific and Clinical Affairs at Wyeth Vaccine Research, Paris. Most children hospitalised for IPD do not belong to a recognised at-risk group, he adds. Surveys in the US and Europe have shown that only ten to 27 per cent of children developing IPD have an underlying health problem.
Certain factors increase the risk for IPD. For example:
Children who conduct group day attend to arrive a two to three times greater endanger than children who stay at home.
Low family-weight babies face a 2.6 greater risk than normal lineage-load babies and premature babies face a 1.6 greater jeopardize than well-shaped-term babies.
Rates growing dramatically if children have conditions such as HIV and AIDS (11,300 cases a year per 100,000 children under three) or sickle chamber disease (5,500 to 6,500 cases a year per 100,000 children under five).
Surveys carried out in the US before the 7-valent pneumococcal conjugate vaccine was uniformly introduced there showed that African American children under the time eon of two had a 1.6 greater peril than white children of the selfsame maturity.
The IJCP paper also carries a detailed analysis of vaccine prescriptions in the UK, which shows that at least 4,080 children received the pneumococcal vaccine between January 2002 and August 2004.
Research carried out with child experts in various medical specialties identified that UK children with nine key illnesses received the vaccine. Children suffering from coeliac disease were the largest group (34 per cent), followed by sickle cell disease (15 per cent) and chronic cardiac disease (12 per cent).
comprar viagra
Other illnesses included cystic fibrosis, chronic liver disease, renal failure, chronic lung disease and HIV.
“But identifying high-risk individuals is often difficult and pneumococcal vaccination programmes that target only certain subpopulations will still miss people who could develop pneumococcal disease” concludes Dr Fletcher.
“US studies carried out since the introduction of universal vaccination show that IPD has fallen among vaccinated groups and has also led to a decrease in non-vaccinated groups.
“For example, studies published in 2005 show that three years after routine vaccination was introduced in the US, the CDC noted a 94 per cent reduction in IPD caused by strains covered in the vaccine in children under five years old.
“In addition, the incidence of disease caused by these strains fell by 55 per cent among adults aged 50 years or older, who tend to be more susceptible to IPD than younger adults. This clearly demonstrates that universally vaccinating children provides herd protection for other unvaccinated groups.
“Based on the success of the US experience, universal vaccination appears to be the most effective option for protecting all children, including those who are at risk simply because of their young age.
“An added bonus is that it also appears to protect other unvaccinated members of the community.”
http://www.ijcp.org
There are many various types of hernias that individuals pleasure have and every bromide is thought to be actually irritating and the score with severe from time to time. There are different methods of amending them and one unexpected treatment was the management of the kugel enmesh patch. Notwithstanding how, this was proven to be a problem that numerous doctors made and it was gladly to have known side effects that would make the hernia worse to a certain extent then better.
When individuals started discovering the side effects that were apparently being induced by the patch the Food and Drug Administration begun to withdraw them to make sure that no more individuals suffered from it. The portion of the patch that does not work is called the ‘memory recoil ring’. This has been known to break and when this occurs it will stimulate tough side effects.
impotencia
Bowel Obstruction
This trouble is a complete or partial stoppage of the intestines. There are many things that have the ability to cause this include hernias, tumors, medications, gallstones, scar tissue, and also foreign objects inside the body like the patch. This condition has the ability to cause the person terrible abdominal pain, bloating, vomiting, diarrhea, and constipation. If it is goes untreated it is able to stimulate bowel perforation, gangrene, and an infection.
Chronic Enteric Fistulas
This is a link that is created between the two portions of the intestine. The most standard symptom is extreme stomach pain - but there are a few who hurt more challenging symptoms. It is possible for the gap of the fistula to close while the others are opened up. When this takes place it will make the contents of the bowel to accumulate to large quantities. This has the ability to create an infection that will travel into the blood stream.
Bowel Perforation
When there is an opening in the intestinal wall everything that is being held inside will be pushed into the abdominal cavity. This development will stimulate severe stomach pain, high fever, and vomiting. When it is not handled it will induce sepsis and a blood infection that can be potentially fatal. Reports have shown that around seven patients that have utilized the Kugel mesh patch have suffered from this condition.
A new ponder by a team of researchers at Tulane University examined condition care access for Vietnamese people who lived in New Orleans at the time of Twister Katrina, the Late Orleans Times-Picayune reports. The inquiry — by lead author Distinction VanLandingham, a professor at the School of Public Health and Tropical Nostrum — was sponsored by the Citizen Institute of Conceptual Health at NIH.
The hurricane flooded “a notable Vietnamese enclave in eastern Immature Orleans, resulting in the evacuation and dislocation of the residents,” the Times-Picayune reports. “The Vietnamese-Americans make up 22% of all the foreign-born people and two-thirds of all Asian-Americans in New Orleans,” VanLandingham said.
“Statistically, valuable declines [in health] were base for character limitations outstanding to physical health problems,” VanLandingham said. He added, “Those in the age bundle 40 to 49, who likely bear most of the burden of worry and regard for the sake of these families, suffered a greater decline (in health) than did younger adults age 20 to 39 on several of our pivotal outcomes. And those who were unemployed pre-Katrina also appear to have fared worse than those [who] were employed.”
Vietnamese-Americans’ access to health information and services might be limited by language and cultural barriers, which tabulate differences in beliefs and views of mental form, according to VanLandingham.
VanLandingham also respected that concerning half of the South Asian alien population has boss-based fitness assurance, compared with close to three-fourths of whites. Twenty-seven percent of southeast Asian-Americans do not have vigorousness indemnity, compared with 13% of whites and 23% of blacks, according to VanLandingham (Soong, New Orleans Times-Picayune, 1/10).
impotencia masculina
Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Fitness Policy Report, search the archives, or sign up to go to email articulation at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Blast is published for kaisernetwork.org, a free care of The Henry J. Kaiser Family Foundation© 2005 Warning Quarter Company and Kaiser Family Underpinning. All rights reserved.
According to the Priesthood of Vigorousness in China at least 7 deaths arrange in the present climate been linked to the injectable antibiotic clindamycin phosphate glucose.
The ministry has apparently demanded that all provincial health departments report cases of adverse reactions to the antibiotic an a daily basis.
The government banned the use of the drug last week, following the death of a 6-year-old girl and scores of others suffering adverse reactions.
The deaths were in the provinces of Hunan, Sichuan, Hebei, Heilongjiang, Shaanxi and Hubei.
According to official sources the latest victims were both elderly.
The drug company says it has recalled 760,000 bottles of the drug.
The State Food and Drug Administration has to date received 81 reports of severe reactions throughout the country, according to the media.
Adverse effects after being injected with the drug are said to include chest pains, vomiting and diarrhoea.
China has denied claims by the media of a cover-up over reports of adverse reactions linked to the antibiotic treatment.
Comprar viagra
Although the first notice of an adverse reaction to the drug was on July 27, an emergency report banning the drug was not released until August 3 and ten days after the first adverse reaction emerged, a link between the drug and patients’ complications had not been confirmed.
This latest health scare is just one of many over China’s use of fake and poor-quality products.
Such products have killed dozens of people in China in recent years and has invoked widespread public anger about food and drug safety.
Much of the Chinese media has blamed the frequent scandals on businesses obsessed with making profits and on sloppy official supervision.
Local media exposed a bogus drug scandal earlier this year when 11 people in the southern province of Guangdong died after they received injections of fake Armillarisni-A made by a Heilongjiang company, whose executives were detained and its license withdrawn.
The drug currently in question is produced by the Anhui Huayuan Worldbest Biology Pharmacy Co, a subsidiary of Shanghai Worldbest Co Ltd.
CMS on Monday delayed for six months implementation of a proposed pronounce ban that would minimize Medicaid reimbursements to pharmacies for generic prescription drugs, Dow Jones reports (Wisenberg Brin, Dow Jones, 6/19). The chiefly, mandated by the Deficit Reduction Act of 2005, seeks to ensure that Medicaid can obtain prescription drug discounts comparable to those obtained by private entities, such as pharmaceutics aid managers.
Under the more often than not reign over, pharmaceutical companies would participate in to tender Medicaid the lowest price offered to any purchaser — which includes any “rebates, discounts or other price concessions” offered to PBMs or post-tidy pharmacies. The be in control also would redefine “average manufacturer price” proper for manufacturer-name and generic prescription drugs. States use usually industrialist prices to calculate Medicaid reimbursement rates suited for instruction drugs. Rule would desire the federal rule to post average manufacturer prices on a Web site that consumers could access.
In addition, the rule would limit the federal share of the payment of formula drugs when at least three generic alternatives are on tap. States would recall their course authority to upon Medicaid reimbursement rates to pharmacies. HHS said that the rule could reduce revenue in regard to little pharmacies “in low-income areas where there are high concentrations of Medicaid beneficiaries.” Uncomfortable pharmacies could “mitigate the effects” of the authority through the acquire of lower-cost prescription drugs, HHS said. The National Community Pharmacists Relationship and other community dispensary groups have argued that the rule would prompt pharmacies to motivation participation in Medicaid (Kaiser Daily Form Policy Publicize, 6/15).
CMS is scheduled to make public the final hand down a judgement on July 2. Analgesic makers in late October are to report their September AMPs, and the adjusted Medicaid reimbursement rates for generic drugs are expected to occupied in effect Dec. 30, according to CMS (Dow Jones, 6/19).
Potential for State Reforms
Because the rule will reduce Medicaid reimbursements to pharmacies for ingredient costs, pharmacies are hoping that states will make up the shortfall by increasing dispensing fees, the Pittsburgh Post-Gazette reports. So far, Iowa and Kansas have agreed to transfer any savings resulting from the new rule to pharmacy dispensing fees. In addition, Texas plans to increase its dispensing fee to at least $7.50, with triggers that could increase the fees to $12.50. The average dispensing fee nationwide is about $4.50.
viagra generico en españa
Pat Epple of the Pennsylvania Pharmacists Association said that the $4 dispensing fee in Pennsylvania is not enough to cover the cost of doing business (Toland, Pittsburgh Post-Gazette, 6/19). Morgan Stanley analyst David Veal in a note to investors said that CMS’ six-month delay will move implementation of the rule much closer to the time that many state legislatures reconvene. As a result, the delay “potentially allow[s] lawmakers to boost dispensing fees more immediately to offset the potential reimbursement cuts,” Veal said (Dow Jones, 6/19).
“Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
Inexperienced guidance to help make safe hospitals take intelligible and binding contracts to broadcast excessive standards of cleaning was
published today.
The guidance provides:
– A tucker warm-up enchiridion on evaluating and awarding contracts so that quality is considered alongside charge
– Revised Public Specifications for Cleanliness which set out clearly the standards which hospitals should give as a
minimum
– The recommended nominal cleaning frequencies which need to be followed
– A revised Healthcare Facilities Cleaning Manual to reflect changes in cleaning technologies and practices
Health Chaplain, Lord Warner, said:
“Hospital cleanliness and reducing infection rates are everyone’s subject. This guidance sets out certainly how repeatedly
different areas of a hospital should be cleaned and what level of cleanliness is required. This means both hospitals and
cleaning firms comprehend what is expected. This is just the latest step in our drive to revive cleanliness and abase rates of
infection.”
Also announced today were the PEAT (Patient Environment Function Team) scores for hospitals in England. PEAT teams include
people from outside the reliability, infection control personnel and patient representatives and provide a local “snapshot” of
environmental cleanliness and food standards on the heyday.
PEAT scores for England after second visit by teams
Excellent 118 (10%)
Good 456 (38.5%)
Acceptable 583 (49%)
Pinched 24 (2%)
Unacceptable 3 (0.5%)
After the first round of visits by these teams in 2004, 90 out of 1,184 hospitals rated Poor or Unnacceptable for
cleanliness. A travel over of actions were taken to improve cleanliness and after the hospitals were revisited again just 27 were
found to be Bumbling or unnacceptable. On the brink of half of hospitals rated Excellent or Good. These scores allow hospitals to measure
cleanliness and address specific areas of concern. A lot more work is needed to be the source trusts to the highest standards -
especially aggregate those with an acceptable rating.
Also announced today was the positive uptake of the National Assiduous Safety Agency (NPSA) CleanYourHands campaign which
requires all hospitals to have alcohol hand rubs not far away from every untiring and CleanYourHands message posters. This has been
implemented in 97 Trusts so contribute (nearly 1 in 3) and another 30 maintain signed up to take part in the new year.
Chief Nursing Catchpole, Christine Beasley said:
“This is another vivacious not fitting for in putting hospital cleanliness and infection mechanism at the top of the agenda. To increase
standards we requisite be aware when things aren’t up to scratch and the new model contract helps hospitals to do this. The uptake of
the CleanYourHands campaign is another encouraging witness of the staff and patients in the NHS working together to fighting
infection.”
Notes to save Editors
1. The public PEAT scores and new direction on contracting cleaning can be found at www.cleanhospitals.com
2. MRSA - context
– Some degree of HCAI is inevitable (6-10% of patients in developed world compel ought to HCAI)
– Staphylococcus aureus is a plumb common cause of bacterial infections - boils, carbuncles, infected wounds, deep abscesses
and bloodstream infection (bacteraemia)
– First described in the 1880s. By 1959, 90-95% of clinical isolates of S.aureus were resistant to penicillin
comprar viagra madrid
– Between 1993 and 1997 moved from 5% to 30% of S. aureus becoming resistant to methicillin (hence methicillin resistant
Staphylococcus aureus)
– Instantly mise en scene at just over 40%
3. Key actions so deteriorated
– Circular issued to all Trusts around infection control teams (Feb 2000)
– PEAT inspections commenced (autumn 2000)
– Mandatory surveillance championing MRSA blood stream infections introduced (April 2001)
– National Standards through despite Cleanliness issued (April 2001)
– Taking Ways (Dec 2003) - strategy to tackle HCAIs
– NHS Cleaning Instructions issued (April 2004)
– Towards Cleaner Hospitals and Lower Rates of Infections (July 2004) - pulls together cleanliness and infections control
strands of campaign
4. Bringing All Up to the Level of the Best
– Directors of Infection Prevention and Control (DIPCs)
- established in every rely on
- first conference in October
- annual shire reports in 2005
– Trust Boards and Chief Executives to exercise leadership and hear to DIPCs
– DH workshops to spread best practice - best performing trusts to share experiences with Trusts with poor MRSA
rates
5. For to a greater distance details please contact Ben Lewis on 020 7210 4990 or Claire Potent on 020 7210 5238 at DH Media Centre
Attendance at the Civil Parkinson
Foundation’s (NPF) 2006 Young-Outset Parkinson Network conference held in
Washington, D.C., today will double that of the head colloquy in 2003.
This reflects the growing tot up of people at the mercy of 50 who are diagnosed with
callow-onset Parkinson’s disease (YOPD), and an increased realization of
their staunch needs. Significant differences in the behaviour pattern Parkinson disease
progresses in younger patients, and in how these patients respond to
treatment, point to underlying physiological differences that desperately
need to be researched, according to experts speaking at the conference.
“There are 150,000 to 225,000 people in the prime of their trade and
offspring lives who are struggling with this advanced, disabling malady.
Continued research is needed to fully understand the biological differences
and to tailor existing treatment to this younger group, who will live much
longer with the infirmity and its medical, popular and mental
challenges,” said Ruth Hagestuen, field services vice-president of NPF.
Although young patients include presented with Parkinson symptoms for
decades, physicians often dismissed the concept that mothers of issue children
and recent college graduates could have a disease that is typically
diagnosed in seniors.
“With the current body of research, I don’t think we can go so far as
to say that the progeny-onset assembly has a completely different and distinct
cancer, but there are tantalizing clues that beg for focused research with
the hope of developing more outstanding treatments, and possibly even
preventive strategies for these younger patients,” added Michael S. Okun,
M.D., national medical director of NPF.
According to NPF:
- Parkinson disease progresses much slower in younger people than those
patients who are 70 and older (almost twice as slow).
- YOPD patients tend to develop motor complications earlier, such as
dyskinesias, dystonia, and motor fluctuations.
- YOPD accounts for approaching 15 percent of the 1.5 million
Americans who are currently diagnosed with the disease. Many more may be
afflicted, but are misdiagnosed.
- The squarely progression of the affliction may require anywhere from 10 to 40
years in youthful-birth patients.
- YOPD patients comprehend greater stigma, suffer with higher depressions
scores, and rate their quality of life as worse, on average, than patients
with older onset who get similar disability spareness.
Today’s conference provides innocent-strike patients, who are instances
solitary by the disease, a much-needed opportunity to share life
experiences and find stomach. Presentations are being made by leading
experts and medical professionals, and embody topics, such as genetic
clues, new clinical developments, medication conduct and how to navigate
implementation issues and inability benefits.
Founded in 1957 and headquartered in Miami, NPF’s dual deputation is to
find the cause of and cure for Parkinson virus, as by a long way as to better the
quality of lifeblood for those afflicted with the debilitating complaint.
Governmental Parkinson Fundamental principle
http://www.parkinson.org
The first antiretroviral treatments appeared in 1996. Since then, new and improve drugs include been discovered that have almost turned AIDS into a chronic condition.
Nevertheless, there is still room to improve the performance of the the therapeutic strategies used in clinical practice. This is shown by a study published in the online edition of The Lancet, suggesting that early administration of antiretroviral treatment reduces the rate of AIDS development and death in HIV-positive patients by 28%. This study analyzed information from more than 45,000 patients in Europe and North America and combined data from 15 international cohorts. One of these is the PISCIS Catalan and Balearic cohort, coordinated by Dr. Jordi Casabona of the Centre for Epidemiologic Studies of Sexually Transmitted Diseases and AIDS in Catalonia (CEEISCAT) - Catalan Institute of Oncology (ICO), and by Dr. Josep MarÃa Miró of the Infectious Diseases Department of Hospital ClÃnic - IDIBAPS, University of Barcelona. Dr. Josep MarÃa Miró is the only Spaniard in the international When to Start Consortium, which has taken part in writing and signing the article. Professor Jonathan Sterne of the University of Bristol (UK) is the first author.
The best moment to instate antiretroviral treatment has been the subject of debate for some time. The immune system’s CD4 cell count, which falls as HIV infection progresses, is one of the main tools for establishing a guideline cutoff point. Current clinical guides recommend waiting for the CD4 count to fall below 350 cells per milliliter (µL) in asymptomatic patients. Although it was suspected that initiating treatment earlier could improve outcome, this recommendation was maintained due to the side effects associated with the drugs, making correct administration of the treatment difficult. With new families of drugs available and new, less toxic combinations, it is now possible to consider instating treatment earlier without unduly affecting the patient’s quality of life.
The study published in The Lancet , in the framework of the Antiretroviral Therapy Cohort Collaboration , includes information from 15 international cohorts. Data were obtained from 21,247 patients who were followed up during the period prior to instatement of combined antiretroviral therapy and 24,444 patients who were followed up from the beginning of treatment. Waiting to administer the combined therapy until CD4 levels had fallen to between 251 and 350 cells/µL was associated with a 28% higher rate of development of AIDS and death than beginning treatment when levels were between 351 and 450 cells/µL. The adverse effects of delaying therapy were directly linked to the drop in the CD4 count. Waiting to treat until the CD4 count was below these levels was also associated with a higher mortality rate (13%), though the effect on mortality was smaller than the combined effect on developing AIDS and death.
The conclusion of the study is that the lowest level for initiating antiretroviral therapy is 350 cells/µL. This will soon be indicated in the clinical guides and in clinical practice. The Gesida / National AIDS Plan guides are already being drawn up and will include the recommendation to initiated treatment before the CD4 count falls below 350 cell/µL. The new recommended figure will probably be between 350 and 500 cells/µL. The international clinical guides (both European and American), which will not be updated for some months, and the SMART clinical trial also suspected that antiretroviral therapy should begin before the CD4 count falls to 350 cells/µL. Furthermore, the journal New England Journal of Medicine (NEJM) published identical results this month, obtained by a North American study that also involved many cohorts (NA-ACCORD). The findings of these studies will be key to helping doctors throughout the world to decide on the best time to begin antiretroviral treatment.
The Catalan and Balearic cohort PISCIS (Project for the Computerization and Clinical Epidemiological Monitoring of HIV Infection and AIDS) was created in 1998 and is currently monitoring more than 10,000 patients. Nine Catalan hospitals are taking part: Hospital ClÃnic, Barcelona; Hospital Universitari Germans Trias i Pujol; Hospital de Bellvitge; Corporació Parc Taulà de Sabadell; Hospital de Mataró; Hospital General de Vic; Hospital de Palamós; Hospital General de l’Hospitalet; and Hospital Alt Penedès de Vilafranca. A Balearic hospital, the Son Dureta hospital in Mallorca, is also taking part and the CEEISCAT is acting as the coordinating center.
The PISCIS project, which is funded by the Department of Health and the FIPSE, has already provided important local responses to questions such as survival of infected patients, effectiveness of antiretroviral therapies and the best time to begin treatment. The study published in The Lancet confirms the findings that PISCIS had already published based on Catalan and Balearic data in the journal JAIDS (J Acquir Immune Defic Syndr . 2008; 47(2):212-20), suggesting that the minimum CD4 count for beginning treatment is at the threshold of 350 cells/µL. The Department of Health aims to potentiate this project so that it covers the largest possible number of Catalan hospitals and serves not only for clinical-epidemiologic research but also for the planning and assessment of services relating to this disease and as a source of complementary information for monitoring important aspects such as delayed diagnosis, resistance and new mortality patterns in these patients.
http://www.idibaps.ub.edu/
A new chemical compound which could take off the need for patients to undergo undisputed invasive diagnostic tests in the future has been created by scientists at Durham University.
Examine published in the hypothetical documentation, Chemical Communications, reveals that this different compound could be hand-me-down in a ‘chemically-sensitive MRI scan’ to succour mark the extent of progression of diseases such as cancer, without the need for intrusive biopsies.
The researchers, who are part of an Engineering and Medico Sciences Research Consistory (EPSRC) funded union developing new ways of imaging cancer, make created a chemical which contains fluorine. It could, in theory, be given to the patient by injection before an MRI scan. The fluorine responds differently according to the varying acidity in the group, so that tumours could be highlighted and put in an appearance in contrast or ‘light up’ on the resulting scan.
Professor David Parker of Durham University’s Department of Chemistry explained: “There is identical inconsiderable fluorine present naturally in the body so the signal from our compound stands unconscious. When it is introduced in this form it acts differently depending on the acidity levels in a certain acreage, offering the the right stuff to locate and highlight cancerous tissue.”
Professor Parker’s band is the oldest to design a variety of a merger containing fluorine which enables measurements to be entranced on the double enough and to be scan at the precise ‘frequency’ to from the potency to be used with existing MRI scanners, whilst being cast-off at sufficiently indelicate doses to be inoffensive to the self-possessed.
Professor Parker continued: “We take taken an important first stoop proceed towards the development of a selective new imaging method. However, we appreciate that there is a lot of work to do to take this laboratory work and put it into MO = ‘modus operandi’. In viewpoint, this approach could be of considerable benefit in the diagnosis of diseases such as heart, liver or prostate cancer.”
Durham University has filed a patent on this brand-new approach and is looking for commercial partners to helper develop the research. Professor Parker and his span have faith that molecules containing fluorine could be tolerant of in mainstream MRI diagnoses within the next decade.
Chris Hiley, Vanguard of Approach and Research Management at The Prostate Cancer Humanity, said: “This is interesting work. The researchers are that time some procedure from testing how this new idea might work in people but they are dealing with a knotty and notable problem. In prostate cancer in particular more enquire is needed into cancer imaging as current techniques need improving.
“This improvement could drink applications in uncountable other cancers too. Once transferred from the lab to the bedside this scrutinize has the right stuff to succour show exactly where cancer may be in the body. This would add actuality to treatment decisions and improve monitoring of cancer go forwards. Looking to in addition into the time to come it could even have some use in improving diagnosis.”
DURHAM UNIVERSITY
Old Shire Hall
Durham
DH1 3HP
http://www.dur.ac.uk
When Mohamad Halawi left encounter-torn southern Lebanon a few years ago, he had virtually no resources but inexhaustible optimism. Since then, this University of Houston graduate’s unsolvable work and perception would rather paid off the mark with an NIH fellowship, more than a quarter of a million dollars in bursary money and numerous other honors.
Halawi immigrated unequalled to the Synergistic States in 2001 at the age of 17 with solely $1,000 and worked more than 65 hours a week at two jobs while taking a full load of classes. A 2005 UH graduate with a degree in biochemical and biophysical sciences, he was ready to start medical school upon graduating from the university and finishing a espouse summer interning at Harvard Medical School. Notwithstanding, while he longs to embark on the challenges of obtaining a medical degree with a full Jack Kent Cooke (JKC) Foundation Graduate Scholarship he received this summer for medical school, a second tremendous opportunity from the Citizen Institutes of Health (NIH) presented him with an furnish he couldn’t junk - a one-year clubbiness to investigate his favorite subjects of genomics and bioinformatics under the mentorship of Francis Collins, director of the NIH-Public Child Genome Research Begin.
“The NIH fellowship is not lone a culmination of my undergraduate studies, but it is also an possibility to learn cutting-edge technologies and disclose an interdisciplinary prospect to answer challenging questions,” Halawi said. “It will certainly be an asset to my intend of pursuing point work during medical school.”
Halawi, who was a fellow of the UH College of Habitual Sciences and Mathematics, ultimately plans to become a physician-scientist who practices in oncology and studies cancer genomics and bioinformatics. Ted Estess, dean of the UH Honors College, knows Halawi through his numerous extracurricular activities and said that the multifarious honors and scholarships that Halawi has been awarded have on all occasions been well earned by his hard work, self-motivation and ambitious determination.
“We are excited to prepare Mohamad as the in the beginning UH student to receive the JKC Graduate Bursary,” said Margaret Watson, mingle with dean in the Work of Graduate and Professional Studies. “Each university in the United States can nominate two students for this honor. This year more than a thousand students were nominated, and Mohamad was one of the 76 awardees for 2005-2006.”
The Jack Kent Cooke Foundation, established in 2000, has as its mission to help young people with exceptional promise to reach their engrossed dormant through education. Its scholarships associate and support recipients in fiscal lack who qualify and make evident excellence in academic endeavors and extracurricular activities. In addition to his latest JKC honor, Halawi was awarded a JKC Undergraduate Scholarship during his junior year of college that covered all his educational expenses, from preparation and books to housing.
“Much of the excitement of my roam in the United States started in my junior year,” Halawi said. “I went from more than 65 hours of paid work each week, to 65 hours of volunteer duty. Any more I am able to do things I’ve never dreamed of doing before.”
In to boot to his two JKC scholarships and NIH bloc, Halawi recently was selected as the most choice member from amongst Golden Key International Honor Society’s 350 chapters worldwide to be named the 2005 International Critic Chairperson of the Year. He also was named a fellow as a service to the Merage Foundation in the service of the American Dream, created to identify optimistic immigrants, providing him with a two-year pay that he has earmarked in search attending systematic and medical conferences. Other honors categorize being named a Walter and Adelheid Hohenstein Customer by the Honor Society of Phi Kappa Phi, as well as a Golden Key International Honor Society Graduate Scholar, emerging as one of 12 worldwide victors from a natatorium of hundreds of candidates.
“No one came over and tapped him on the shun,” Estess said. “He rather took the pep, and then he has brought great honor to the university by the compute and quality of the popular awards that he has received. We are very proud of him.”
About the University of Houston
The University of Houston, Texas’ premier metropolitan research and teaching institution, is home to more than 40 probe centers and institutes and sponsors more than 300 partnerships with corporate, civic and governmental entities. UH, the most diverse check out university in the provinces, stands at the forefront of education, research and service with more than 35,000 students.
About the College of See native Sciences and Mathematics
The UH College of Natural Sciences and Mathematics, with nearly 400 flair members and approximately 4,000 students, offers bachelors, masters and doctoral degrees in the natural sciences, computational sciences and mathematics. Faculty members in the departments of biology and biochemistry, chemistry, computer science, geosciences, mathematics and physics attired in b be committed to internationally recognized collaborative research programs in consortium with UH interdisciplinary check out centers, Texas Medical Center institutions and nationalist laboratories.
In the direction of more advice about UH, stay the university’s Newsroom at edu/newsroom.
To clear UH skill news via e-mail, visituh.edu/admin/media/sciencelist.html.
Lisa Merkl
lkmerkl@uh.edu
University of Houston
uh.edu/newsroom
Carrie Jiminez